FDA: WILL NOT BEGIN PROCEDURES TO WITHDRAW APPROVAL OF ABBREVIATED NEW DRUG APPLICATIONS THAT REFER TO NAMENDA PRODUCTS - FEDERAL REGISTER

Reuters · 2d ago

Please log in to view news